Hydrogen membrane transport activity coupled with changing deuterium/hydrogen ratio may be a key proliferation signal for the cells
Gábor
Somlyai1*,
Lajos
Nagy2,
László
Puskás2,
Gabriella
Fábián2,
Zoltán
Gyöngyi3,
Krisztina
Krempels1,
Ildikó
Somlyai1,
Gábor
Laskay4,
Gábor
Jancsó5,
György
Jákli5,
András
Kovács6,
Imre
Guller6,
Daiana
S.
Ávila7 and
Michael
Aschner7
-
1
HYD Ltd. for Cancer Research and Drug Development, Hungary
-
2
Avidin Biotechnology Ltd., Hungary
-
3
University of Pécs, Hungary
-
4
Department of Botany, University of Szeged, Hungary
-
5
KFKI Atomic Energy Research Institute, Hungary
-
6
Saint John's Hospital, Hungary
-
7
Vanderbilt University Medical Center, United States
Background and aim. The deuterium/hydrogen (D/H) mass ratio is the largest among stable isotopes of the same element, causing differences in the chemical behavior between the two hydrogen isotopes. Although the concentration of D is more than 10 mM (150 ppm) in living organisms, the potential role of D was not investigated for six decades after its discovery. In order to reveal the possible role of naturally occurring D in living organisms, the consequence of the shortage of D was investigated in different biological systems such as cell cultures, animal studies and human clinical trials.
Materials and Methods. In order to reduce the D-concentration in different biological systems below the natural level, we used deuterium-depleted water (DDW) in a range of 25 ppm and 135 ppm D. DDW was produced by fractional distillation. A microelectronic cell sensor method (xCELLigence RTCA SP) was used to follow the cell growth of cancer cells in real-time.
Results. The experiments with DDW revealed that due to D-depletion (135-40 ppm) the cell growth of various cell lines (HT199 melanoma, A549 lung and MCF-7 breast cancer) was inhibited in vitro. Even 1 ppm decrease in D-concentration of the media in every 8 hours was associated with a lower growth rate. The results also revealed that increasing the D-concentration over the natural level (200-800 ppm) stimulated cell growth. Simultaneous DDW administration enhanced the growth-controlling effect of anticancer drugs. Deuterium depletion (DD) decreased the rate of recovery of the cytoplasmic pH of the cells (an IL-3-dependent murine haemopoietic cell line FDCP-Mix cloneA4) from acid load, an indicator of the activity of the Na+/H+ antiport. In the same cells DD increased the rate of apoptosis induced by IL-3 deprivation. DD also inhibited the expression of genes (c-myc, H-Ras, Bcl-2, K-Ras, COX-2) having key role in tumor development or restored the expression of genes having key role in aging (DAF-16, SOD, Akt). Replacing the normal daily water intake with DDW (25 ppm D), it induced complete or partial tumor regression in dogs and cats. In human clinical studies the integration of DDW (25-105 ppm) into conventional therapies resulted a 2-3 fold increase in median survival time of patients with prostate, breast and lung cancer.
Conclusions. It is suggested that cells are readily able to regulate their D/H ratios, while these changes trigger distinct molecular processes. One possibility to modify intracellular D/H ratios is the activation of the H+-transport system, which preferentially eliminates H+, resulting an increased D/H ratio within the cells. Altered D/H ratios strongly regulate the expression of distinct genes and the activity of enzymes having key role in cell cycle regulation and also control various molecular mechanisms. We contemplate that naturally occurring D is a key element of a still obscure sub-molecular regulatory system (SMRS). Deuterium depletion opens new perspectives in cancer treatment and prevention offering a completely safe and non-invasive treatment modality.
References
Somlyai, G., et al. (1993) Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Letters, 1993, 317, 1-4.; Kotyk, A., et al.: Deuterons cannot replace protons in active transport processes in yeast. FEBS Letters, 1990, 264(2), 203-205.
Keywords:
deuterium depletion,
anticancer drug,
deuterium depleted water,
DDW,
somlyai
Conference:
4th Annual Meeting of the International Society of Proton Dynamics in Cancer, Garching, Germany, 10 Oct - 12 Oct, 2013.
Presentation Type:
Abstract
Topic:
9. Acidity as a target for antitumor therapy
Citation:
Somlyai
G,
Nagy
L,
Puskás
L,
Fábián
G,
Gyöngyi
Z,
Krempels
K,
Somlyai
I,
Laskay
G,
Jancsó
G,
Jákli
G,
Kovács
A,
Guller
I,
Ávila
DS and
Aschner
M
(2014). Hydrogen membrane transport activity coupled with changing deuterium/hydrogen ratio may be a key proliferation signal for the cells.
Front. Pharmacol.
Conference Abstract:
4th Annual Meeting of the International Society of Proton Dynamics in Cancer.
doi: 10.3389/conf.fphar.2014.61.00044
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
17 Dec 2013;
Published Online:
07 Feb 2014.
*
Correspondence:
Dr. Gábor Somlyai, HYD Ltd. for Cancer Research and Drug Development, Budapest, Hungary, gsomlyai@hyd.hu